Evaluation of Ultrasonography in High Precision Radiotherapy of Cervical Cancers.

Evaluation and Validation of Ultrasonography in Radiotherapeutic Management of Cervical Cancers.

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2013/12/004207

Enrollment

Registered

2013-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Histologically proven Cervical Cancers suitable for Radical Radiation therapy with/ without concomitant chemotherapy and HDR brachytherapy.

Interventions

Intervention1: Trans-Abdominal Ultrasonography (TAUS)as an IGRT Tool: As a part of IGRT protocol, patients will undergo CT (Computed Tomography) planning followed by CBCT based IGRT for set-up and mat

Eligibility

Inclusion criteria

Inclusion criteria: Histologically proven Cervical Cancers suitable for Radical Radiation therapy with/without concomitant chemotherapy and HDR brachytherapy.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
To establish utero-cervical and cervix including primary tumor movements during the course of EBRT. To establish Clincial Target Volume (CTV) and Internal Target Volume (ITV) margins for primary cervical tumor related target volume.Timepoint: 2 years	—

Secondary

Measure	Time frame
US based Intracavitary brachytherapy planningTimepoint: 12 months	—

Countries

India

Contacts

Public ContactDr Umesh Mahantshetty

Tata Memorial Hospital

drumeshm@gmail.com022-24177168

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026